On January 20th, Livzon Pharma spent approximately 9.9981 million yuan to repurchase 274,900 A-shares.

date
20/01/2025
avatar
GMT Eight
LIVZON PHARMA (01513) announced that it will purchase approximately 27.49 million A-shares for about 9.9981 million yuan on January 20, 2025.
pre
YEE HOP HLDGS (01662) trading unit will be changed to 1000 shares per lot.
Hangzhou Alltest Biotech (688606.SH) released a pre-increase forecast, with an expected net profit of 278 million to 298 million yuan in 2024, a year-on-year increase of 53.95% to 65.03%.
next

RECOMMEND

recommend

Song Xuetao: What incremental signals were released at the press conference of the five ministries?

date
19 min ago
recommend

Morgan Stanley: Key points for visiting the Chinese humanoid Siasun Robot & Automation industry

date
32 min ago
recommend

National Bureau of Statistics interpretation: The current moderate rebound in prices has not changed.

date
42 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com